Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Cameron

Showing results (1551-1560 of 1,688) with videos related to

Pageof 169
Sort By:
The Lancet. Oncology|May 17, 2011
TP53 status for prediction of sensitivity to taxane versus non-taxane neoadjuvant chemotherapy in breast cancer (EORTC 10994/BIG 1-00): a randomised phase 3 trialHervé Bonnefoi, Martine Piccart, Jan Bogaerts, et al.
European Journal of Cancer (Oxford, England : 1990)|August 14, 2012
Trial design on prophylaxis and treatment of brain metastases: lessons learned from the EORTC Brain Metastases Strategic Meeting 2012Matthias Preusser, Frank Winkler, Laurence Collette, et al.
The Oncologist|May 11, 2025
Patient-reported outcomes from DESTINY-Breast04: trastuzumab deruxtecan versus physician's choice of chemotherapy in patients with HER2-low mBCNaoto T Ueno, Francesco Cottone, Kyle Dunton, et al.
Cell Stem Cell|April 24, 2018
Human Adult Neurogenesis: Evidence and Remaining QuestionsGerd Kempermann, Fred H Gage, Ludwig Aigner, et al.
European Heart Journal|February 2, 2018
Mortality associated with heart failure with preserved vs. reduced ejection fraction in a prospective international multi-ethnic cohort studyCarolyn S P Lam, Greg D Gamble, Lieng H Ling, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|December 16, 2017
Value of Information Analysis of Multiparameter Tests for Chemotherapy in Early Breast Cancer: The OPTIMA Prelim TrialPeter S Hall, Alison Smith, Claire Hulme, et al.
Plos One|March 13, 2014
Genetic polymorphism rs6922269 in the MTHFD1L gene is associated with survival and baseline active vitamin B12 levels in post-acute coronary syndromes patientsBarry R Palmer, Sandy Slow, Katrina L Ellis, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|November 17, 2024
Daily or Twice Daily Treatment With Topical Steroids Results in Similar Responses in Eosinophilic EsophagitisCraig C Reed, Sean S LaFata, Timothy S Gee, et al.
Injury|October 15, 2019
Over view of major traumatic injury in Australia--Implications for trauma system designP A Cameron, M C Fitzgerald, K Curtis, et al.
Breast Cancer Research and Treatment|March 1, 2023
Aromatase inhibition plus/minus Src inhibitor saracatinib (AZD0530) in advanced breast cancer therapy (ARISTACAT): a randomised phase II studyAilsa J Oswald, Stefan N Symeonides, Duncan Wheatley, et al.
Pageof 169

Showing results (1551-1560 of 1,688) with videos related to

Sort By:
Pageof 169
The Lancet. Oncology|May 17, 2011
TP53 status for prediction of sensitivity to taxane versus non-taxane neoadjuvant chemotherapy in breast cancer (EORTC 10994/BIG 1-00): a randomised phase 3 trialHervé Bonnefoi, Martine Piccart, Jan Bogaerts, et al.
European Journal of Cancer (Oxford, England : 1990)|August 14, 2012
Trial design on prophylaxis and treatment of brain metastases: lessons learned from the EORTC Brain Metastases Strategic Meeting 2012Matthias Preusser, Frank Winkler, Laurence Collette, et al.
The Oncologist|May 11, 2025
Patient-reported outcomes from DESTINY-Breast04: trastuzumab deruxtecan versus physician's choice of chemotherapy in patients with HER2-low mBCNaoto T Ueno, Francesco Cottone, Kyle Dunton, et al.
Cell Stem Cell|April 24, 2018
Human Adult Neurogenesis: Evidence and Remaining QuestionsGerd Kempermann, Fred H Gage, Ludwig Aigner, et al.
European Heart Journal|February 2, 2018
Mortality associated with heart failure with preserved vs. reduced ejection fraction in a prospective international multi-ethnic cohort studyCarolyn S P Lam, Greg D Gamble, Lieng H Ling, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|December 16, 2017
Value of Information Analysis of Multiparameter Tests for Chemotherapy in Early Breast Cancer: The OPTIMA Prelim TrialPeter S Hall, Alison Smith, Claire Hulme, et al.
Plos One|March 13, 2014
Genetic polymorphism rs6922269 in the MTHFD1L gene is associated with survival and baseline active vitamin B12 levels in post-acute coronary syndromes patientsBarry R Palmer, Sandy Slow, Katrina L Ellis, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|November 17, 2024
Daily or Twice Daily Treatment With Topical Steroids Results in Similar Responses in Eosinophilic EsophagitisCraig C Reed, Sean S LaFata, Timothy S Gee, et al.
Injury|October 15, 2019
Over view of major traumatic injury in Australia--Implications for trauma system designP A Cameron, M C Fitzgerald, K Curtis, et al.
Breast Cancer Research and Treatment|March 1, 2023
Aromatase inhibition plus/minus Src inhibitor saracatinib (AZD0530) in advanced breast cancer therapy (ARISTACAT): a randomised phase II studyAilsa J Oswald, Stefan N Symeonides, Duncan Wheatley, et al.
Pageof 169